A summary of the findings for the FORMAMP project is presented at Cordis, read more here
The FORMAMP project focus on innovative nanoformulation design of antimicrobial peptides
The long-term objective of the FORMAMP project is to significantly change the treatment strategies for infectious diseases and to reduce the drastic increase of resistant bacteria.
The project aims to develop new and innovative formulation strategies, based on the combination of nanotechnology-based delivery systems and antimicrobial peptides (AMPs), for the treatment of infectious diseases caused by bacteria such as Pseudomonas aeruginosa, Methicillin-resistant Staphylococcus aureus (MRSA), and Mycobacterium tuberculosis.
FORMAMP is funded by the European Union’s Seventh Framework Programme (FP7/2007-2013) under grant agreement no 604182.